← All companies

ITRM

Iterum Therapeutics plc

ITRMF OTC Pharmaceutical Preparations EDGAR ↗

$0.03

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$1.38M

Revenue (TTM)

$0.00

Net income (TTM)

-$27.0M

EPS (TTM)

$-0.70

P/E ratio

—

Dividend yield

—

Free cash flow

-$26.8M

Cash

$11.0M

Total assets

$32.5M

Gross margin

—

52-week range

$0.01 – $0.91

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Delisting notice or listing-rule failure; Other events Mar 31, 2026 8-K Bankruptcy or receivership; Triggering event accelerating an obligation; Director or officer change; Regulation FD disclosure Mar 27, 2026 8-K Other events Mar 3, 2026 8-K Delisting notice or listing-rule failure Mar 2, 2026 8-K Shareholder vote results; Other events Feb 18, 2026 8-K Delisting notice or listing-rule failure Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Other events Oct 16, 2025 8-K Shareholder vote results Sep 10, 2025 8-K Delisting notice or listing-rule failure Aug 28, 2025 8-K Regulation FD disclosure; Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Entered a material agreement Aug 4, 2025 8-K Other events Jul 18, 2025 8-K Entered a material agreement Jun 11, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure May 19, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Entered a material agreement; Other events Apr 30, 2025 8-K Director or officer change; Other events Mar 10, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Feb 14, 2025 10-K Fiscal year ended 2024-12-31 Feb 7, 2025 8-K Results of operations (earnings release) Feb 7, 2025 8-K Other events Dec 11, 2024 8-K Other events Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Took on a direct financial obligation Nov 1, 2024 8-K Regulation FD disclosure; Other events Oct 25, 2024 8-K Delisting notice or listing-rule failure Oct 15, 2024 8-K Shareholder vote results Oct 8, 2024 8-K Delisting notice or listing-rule failure Oct 4, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 8-K Other events Aug 6, 2024 8-K Other events Jul 22, 2024 8-K Other events Jun 26, 2024 8-K Shareholder vote results; Other events Jun 21, 2024